Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
09/02/2009
Trade Name:
Intuniv
Generic or Proper Name (*):
guanfacine
Indications Studied:
ADHD
Therapeutic Category:
Non-stimulant ADHD treatment
Ages Studied:
6-17 years
Study #:
4
Study Type:
Pharmacokinetic
Study Design:
Open Label/Traditional Pharmacokinetic
No Patients:
28
No Centers:
1
No Countries:
1
BPCA(B), PREA(P):
P
-
-